Financials
- Market Capitalization 5.18 M
- Employee 17
- Founded 2015
- CEO N/A
- Website www.moleculin.com
- Headquarter Delaware, United States
- FIGI BBG00B9T47L9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4892 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.02 USD | -0.98% | -26.55% | +1.51% | -9.21% | 5.56 M USD | ||
| 4893 | BCAB BioAtla, Inc. - Common Stock | 3.37 USD | -0.30% | -3.16% | -17.80% | +862.86% | 5.58 M USD | ||
| 4906 | CURX Curanex Pharmaceuticals Inc - Common Stock | 0.20 USD | +5.26% | 0.00% | -31.03% | -94.74% | 5.67 M USD | ||
| 4908 | ENVB Enveric Biosciences, Inc. - Common Stock | 1.45 USD | 0.00% | +14.17% | +5.07% | -40.94% | 5.34 M USD |
Frequently asked questions about Moleculin Biotech, Inc. - Common Stock
What is the Moleculin Biotech, Inc. - Common Stock stock price today?
The current price of Moleculin Biotech, Inc. - Common Stock (MBRX) is 0.97. Over the past 24 hours, the stock has changed by -4.90%. Follow the MBRX chart for real-time price dynamics.
What is the stock ticker of Moleculin Biotech, Inc. - Common Stock?
Moleculin Biotech, Inc. - Common Stock trades under the ticker MBRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Moleculin Biotech, Inc. - Common Stock stock going up?
MBRX has changed by -54.46% over the last week, -62.55% over the last month, and -69.21% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Moleculin Biotech, Inc. - Common Stock?
Moleculin Biotech, Inc. - Common Stock currently has a market capitalization of 5.18 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Moleculin Biotech, Inc. - Common Stock earnings last quarter?
Last quarter, Moleculin Biotech, Inc. - Common Stock reported earnings of -3.54 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Moleculin Biotech, Inc. - Common Stock revenue for the last quarter?
Moleculin Biotech, Inc. - Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Moleculin Biotech, Inc. - Common Stock net income for the last quarter?
Moleculin Biotech, Inc. - Common Stock reported net income of -12.85 M for the last quarter. The previous quarter showed 15.55 M, which means net income changed by -182.59%.
How many employees does Moleculin Biotech, Inc. - Common Stock have?
As of the latest available data, Moleculin Biotech, Inc. - Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Moleculin Biotech, Inc. - Common Stock stock?
You can buy Moleculin Biotech, Inc. - Common Stock (MBRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Moleculin Biotech, Inc. - Common Stock stock?
Investing in Moleculin Biotech, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MBRX chart and related analysis on metatrader.com as part of your research.